Edwards Lifesciences Corp (EW):企業の財務・戦略的SWOT分析

◆英語タイトル:Edwards Lifesciences Corp (EW) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1300
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Edwards Lifesciences Corp (EW) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Edwards Lifesciences Corp (Edwards Lifesciences) is a medical technology company that develops, manufactures and markets devices for structural heart disease, critical care and surgical monitoring. The company’s products include surgical valve repair devices, surgical valve replacement, transcatheter heart valves, hemodynamic monitoring devices, pressure monitoring devices, and related instruments and accessories. Its products find application in various therapies, including transcatheter aortic valve replacement (TAVR), blood conservation, infection control, enhanced surgical recovery, and for the management of clotting, hypotension and sepsis. The company markets products through direct sales force and also a network of independent distributors in North America, Europe and Asia-Pacific, among others. Edwards Lifesciences is headquartered in Irvine, California, the US.

Edwards Lifesciences Corp Key Recent Developments

Mar 28,2020: Edwards pauses enrollments in pivotal mitral, tricuspid trials in response to hospitals’ focus on COVID-19
Feb 21,2020: Edwards Lifesciences’ Every Heartbeat Matters Philanthropic Initiative expanding to reach more patients
Jan 30,2020: Edwards Lifesciences reports fourth quarter results
Dec 05,2019: Edwards Lifesciences outlines growth strategy at annual investor conference 2019
Oct 23,2019: Edwards Lifesciences reports third quarter results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Edwards Lifesciences Corp – Key Facts
Edwards Lifesciences Corp – Key Employees
Edwards Lifesciences Corp – Key Employee Biographies
Edwards Lifesciences Corp – Major Products and Services
Edwards Lifesciences Corp – History
Edwards Lifesciences Corp – Company Statement
Edwards Lifesciences Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Edwards Lifesciences Corp – Business Description
Product Category: Critical Care
Overview
Performance
Product Category: Surgical Structural Heart
Overview
Performance
Product Category: Transcatheter Aortic Valve Replacement
Overview
Performance
Product Category: Transcatheter Mitral and Tricuspid Therapies
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
R&D Overview
Edwards Lifesciences Corp – Corporate Strategy
Edwards Lifesciences Corp – SWOT Analysis
SWOT Analysis – Overview
Edwards Lifesciences Corp – Strengths
Edwards Lifesciences Corp – Weaknesses
Edwards Lifesciences Corp – Opportunities
Edwards Lifesciences Corp – Threats
Edwards Lifesciences Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Edwards Lifesciences Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
Edwards Lifesciences Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 21, 2020: Edwards Lifesciences’ Every Heartbeat Matters Philanthropic Initiative expanding to reach more patients
Jan 30, 2020: Edwards Lifesciences reports fourth quarter results
Dec 05, 2019: Edwards Lifesciences outlines growth strategy at annual investor conference 2019
Oct 23, 2019: Edwards Lifesciences reports third quarter results
Oct 10, 2019: CINDE announces Edwards Lifesciences invests $100 million to expand its operations in Costa Rica
Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019
Jun 21, 2019: Edwards comments on updated TAVR National Coverage Determination
Apr 23, 2019: Edwards Lifesciences announces first quarter results
Feb 13, 2019: Edwards Lifesciences to buy CASMED for $100m
Jan 31, 2019: Edwards Lifesciences reports financial results for the quarter ended December 31, 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Edwards Lifesciences Corp, Key Facts
Edwards Lifesciences Corp, Key Employees
Edwards Lifesciences Corp, Key Employee Biographies
Edwards Lifesciences Corp, Major Products and Services
Edwards Lifesciences Corp, History
Edwards Lifesciences Corp, Other Locations
Edwards Lifesciences Corp, Subsidiaries
Edwards Lifesciences Corp, Key Competitors
Edwards Lifesciences Corp, Ratios based on current share price
Edwards Lifesciences Corp, Annual Ratios
Edwards Lifesciences Corp, Annual Ratios (Cont...1)
Edwards Lifesciences Corp, Annual Ratios (Cont...2)
Edwards Lifesciences Corp, Interim Ratios
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Edwards Lifesciences Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
Edwards Lifesciences Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Edwards Lifesciences Corp, Performance Chart (2015 - 2019)
Edwards Lifesciences Corp, Ratio Charts
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Edwards Lifesciences Corp, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Edwards Lifesciences Corp (EW):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Salvatore Ferragamo SpA (SFER):企業の財務・戦略的SWOT分析
    Salvatore Ferragamo SpA (SFER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • CRELUX GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Crelux GmbH (Crelux), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a drug discovery company that discovers drug solutions for pharmacy, biotech and research organizations. The company offers customized and integrated services in areas of drug discovery, X-ray crystallography, protein su …
  • SGD S.A.:企業の戦略・SWOT・財務情報
    SGD S.A. - Strategy, SWOT and Corporate Finance Report Summary SGD S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Tallgrass Energy Partners, LP (TEP):石油・ガス:M&Aディール及び事業提携情報
    Summary Tallgrass Energy Partners LP (Tallgrass Energy), a midstream oil and gas company.. It offers natural gas transportation and storage services to customers in the Rocky Mountains and Midwest regions of the US. The company also provides crude oil transportation to customers in Wyoming, Colorado …
  • Petrel Energy Ltd (PRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrel Energy Ltd (Petrel Energy), formerly Orion Petroleum Ltd, is an petroleum exploration, development and production company. The company offers exploitation of petroleum products and produces crude oil using conventional and unconventional methods. It holds tenements in the Norte Basin, …
  • Hague and London Oil PLC (HNL):企業の財務・戦略的SWOT分析
    Summary Hague and London Oil PLC (HALO), formerly Wessex Exploration plc, is an oil and gas exploration company that develops resource properties. The company acquires, explores, produces, and develops oil and gas resource properties across the UK. Its projects comprise assets in the Philippines, Gu …
  • SPX Corporation:企業の戦略・SWOT・財務情報
    SPX Corporation - Strategy, SWOT and Corporate Finance Report Summary SPX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SENER Grupo de Ingenieria SA-エネルギー分野:企業M&A・提携分析
    Summary SENER Grupo de Ingenieria SA (SENER) is a construction company that offers engineering services. The company’s services include marine infrastructures, environmental projects, hydraulic engineering, architecture and urban planning. It offers turnkey solutions and operates projects on space, …
  • Vector Ltd (VCT):企業の財務・戦略的SWOT分析
    Vector Ltd (VCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Suelopetrol CA SACA:企業の戦略的SWOT分析
    Suelopetrol CA SACA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Northern Trust Corporation:企業のM&A・事業提携・投資動向
    Northern Trust Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Northern Trust Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • TauRx Pharmaceuticals Ltd:医療機器:M&Aディール及び事業提携情報
    Summary TauRx Pharmaceuticals Ltd (TauRx) discovers, develops and commercializes treatments and diagnostics for Alzheimer's disease and other neurodegenerative diseases. Its pipeline products include LMTX, a tau aggregation inhibitor (TAI) for Alzheimer’s and Behavioural variant frontotemporal demen …
  • Oi S.A.:企業の戦略・SWOT・財務情報
    Oi S.A. - Strategy, SWOT and Corporate Finance Report Summary Oi S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Protege Energy III LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Protege Energy III LLC (Protege Energy) is an oil and gas exploration and production company. The company offers acquisition and development of oil and gas reserves including exploration, development, operations, horizontal drilling, reservoir stimulations, recompletions, artificial lift and …
  • Sao Martinho SA (SMTO3):企業の財務・戦略的SWOT分析
    Sao Martinho SA (SMTO3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Municipal Energy Agency of Nebraska:発電所・企業SWOT分析
    Municipal Energy Agency of Nebraska – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Electricity Generating Authority of Thailand:電力:M&Aディール及び事業提携情報
    Summary Electricity Generating Authority of Thailand (EGAT) is a state-owned power utility. It generates, procures, transmits, and distributes electricity. The authority produces energy using hydro, coal, natural gas, diesel, fuel oil and palm oil, and renewable sources. EGAT procures electricity fr …
  • Aerin Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Aerin Medical Inc (Aerin) develops a non-invasive medical device that treats nasal obstruction and breathing disorders. The company develops VIVAER, an advanced treatment platform that treats nasal congestion and remodel nasal soft tissues utilizing low-power radio frequency energy. Its trea …
  • Vivus Inc (VVUS):企業の財務・戦略的SWOT分析
    Vivus Inc (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nuevolution AB (NUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuevolution AB (Nuevolution) is a biopharmaceutical company focused on developing drug treatments for cancer and chronic inflammatory diseases. The company’s pipeline products include RORyt inhibitor, BRD (BD1), cytokine X, RORyt agonist, and GRP78. Its products are used for various indicati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆